DName-iT Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.99M

  • Investors
  • 5

DName-iT General Information

Description

Developer of a genetic testing technology designed to avoid sample authentication errors. The company's core product molecules allow absolute control and automation of a broad range of tests in different fields in genetic labs, where one can confirm the patient's identity, avoiding independent patient validation steps such as additional SNP fingerprint testing, making the entire NGS workflow less time-consuming and more cost-efficient, enabling lab owners to test samples more effectively and efficiently.

Contact Information

Website
www.dnameit.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Concourse Building 3
  • The Titanic Quarter, 6 Queens Road
  • Belfast BT3 9DT
  • Northern Ireland, United Kingdom
+44 020
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Vertical(s)
Corporate Office
  • Concourse Building 3
  • The Titanic Quarter, 6 Queens Road
  • Belfast BT3 9DT
  • Northern Ireland, United Kingdom
+44 020

DName-iT Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DName-iT Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 30-Jan-2026 $1.99M Completed Generating Revenue
4. Secondary Transaction - Private Completed Generating Revenue
3. Later Stage VC 30-Jun-2023 Completed Generating Revenue
2. Early Stage VC 07-Jan-2015 Completed Startup
1. Early Stage VC Completed Startup
To view DName-iT’s complete valuation and funding history, request access »

DName-iT Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
Ordinary Shares
Ordinary Shares 171,611 $0.013508 $2.31 $2.31 1x $2.31 7.95%
Ordinary Shares 182,482 $0.013508 $1.85 $1.85 1x $1.85 8.46%
To view DName-iT’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

DName-iT Patents

DName-iT Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260327681-A1 Methods for identification of samples Pending 11-Apr-2025
GB-201701908-D0 Methods for identification of samples Inactive 06-Feb-2017
AU-2017266299-A1 Methods for identification of samples Inactive 17-May-2016
AU-2023229558-A1 Methods for identification of samples Active 17-May-2016
AU-2023229558-B2 Methods for identification of samples Active 17-May-2016 C12Q1/6869
To view DName-iT’s complete patent history, request access »

DName-iT Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DName-iT Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
BNP Paribas Investment Bank Minority
KBC Group Corporation Minority
KU Leuven Research & Development University Minority
MNL Nominees Corporation Minority
EMV Capital Venture Capital Minority
To view DName-iT’s complete investors history, request access »

DName-iT FAQs

  • When was DName-iT founded?

    DName-iT was founded in 2014.

  • Where is DName-iT headquartered?

    DName-iT is headquartered in Belfast, United Kingdom.

  • What is the size of DName-iT?

    DName-iT has 2 total employees.

  • What industry is DName-iT in?

    DName-iT’s primary industry is Laboratory Services (Healthcare).

  • Is DName-iT a private or public company?

    DName-iT is a Private company.

  • What is the current valuation of DName-iT?

    The current valuation of DName-iT is .

  • What is DName-iT’s current revenue?

    The current revenue for DName-iT is .

  • How much funding has DName-iT raised over time?

    DName-iT has raised $2.68M.

  • Who are DName-iT’s investors?

    BNP Paribas, KBC Group, KU Leuven Research & Development, MNL Nominees, and EMV Capital have invested in DName-iT.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process